| Stage | AHR | % of rev | RHP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $674M | 100.00% | $749M | 100.00% | RHP ×1.11 |
| Gross profit | $149M | 22.16% | $365M | 48.72% | RHP +26.6pp |
| Operating income | $41M | 6.04% | $175M | 23.30% | RHP +17.3pp |
| Pre-tax income | $31M | 4.59% | $114M | 15.24% | RHP +10.6pp |
| Net income | $31M | 4.59% | $102M | 13.63% | RHP +9.0pp |
| Stage | AHR | RHP | Gap · A − B |
|---|---|---|---|
| Revenue | $674M100.00% | $749M100.00% | RHP ×1.11 |
| Gross profit | 22.16%$149M | 48.72%$365M | RHP +26.6pp |
| Operating income | 6.04%$41M | 23.30%$175M | RHP +17.3pp |
| Pre-tax income | 4.59%$31M | 15.24%$114M | RHP +10.6pp |
| Net income |
| 4.59%$31M |
| 13.63%$102M |
| RHP +9.0pp |
No shared counterparties.